COX-2 Expression in Canine Normal and Neoplastic Mammary Gland

Journal of Comparative Pathology

Volumn 140, Issue 4, 2009, Pages 247-253

  Dias Pereira, P ^a   Lopes, C C ^a   Matos, A J F ^a   Santos, M ^a   Gartner F ^a   Medeiros, R ^b   Lopes, C ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

cyclooxygenase 2; dog; mammary gland; neoplasia

Indexed keywords

CYCLOOXYGENASE 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST TUMOR; CANCER INVASION; CELL LABELING; CONTROLLED STUDY; CYTOPLASM; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ANIMALS; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM METASTASIS; NEOPLASMS;

CANIS FAMILIARIS;

EID: 63349110467     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2008.12.005     Document Type: Article

References (30)

1. Borellini F., and Oka T. Growth control and differentiation in mammary epithelial cells. Environmental Health Perspectives 80 (1989) 85-99
2. Brueggemeier R., Quinn A., Parrett M., Joarder F., Harris R., and Robertson F. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Letters 140 (1999) 27-35
3. Brunelle M., Sartin E., Wolfe L., Sirois J., and Doré M. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines. Veterinary Pathology 43 (2006) 656-666
4. Dannhardt G., and Kiefer W. Cyclooxygenase inhibitors - current status and future prospects. European Journal of Medicinal Chemistry 36 (2001) 109-126
5. Davies G. Cyclooxygenase-2 and chemoprevention of breast cancer. Journal of Steroid Biochemistry and Molecular Biology 86 (2003) 495-499
6. Dempke W., Rie C., Grothey A., and Schmoll H. Cyclooxygenase-2: a novel target for cancer chemotherapy?. Journal of Cancer Research and Clinical Oncology 127 (2001) 411-417
7. Denkert C., Winzer K., Müller B., Weichert W., Pest S., Kobel M., Kristiansen G., Reles A., Siegert A., Guski H., and Hauptmann S. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer 97 (2003) 2978-2987
8. Doré M., Lanthier I., and Sirois J. Cyclooxygenase-2 expression in canine mammary tumors. Veterinary Pathology 40 (2003) 207-212
9. Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Annals of Clinical Laboratory Science 30 (2000) 3-21
10. Half E., Tang X., Gwyn K., Sahin A., Wathen K., and Sinicrope F. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Research 62 (2002) 1676-1681
11. Heller D., Clifford C., Goldschmidt M., Holt D., Shofer F., Smith A., and Sorenmo K. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma. Veterinary Pathology 42 (2005) 776-780
12. Howlin J., McBryan J., and Martin F. Pubertal mammary gland development: insights from mouse models. Journal of Mammary Gland Biology and Neoplasia 11 (2006) 283-297
13. Hsu S., Raine L., and Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. American Journal of Clinical Pathology 75 (1981) 816-821
14. Leo C., Faber S., Hentschel B., Hockel M., and Horn L.C. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Annals of Diagnostic Pathology 10 (2006) 327-332
15. Liou J., Deng W., Gilroy D., Shyue S., and Wu K. Co-localization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. Journal of Biological Chemistry 276 (2001) 34975-34982
16. Liu C., Chang S., Narko K., Trifan O., Wu M., Smith E., Haudenschild C., Lane T., and Hla T. Over-expression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. Journal of Biological Chemistry 276 (2001) 18563-18569
17. Millanta F., Citi S., Della Santa D., Porciani M., and Poli A. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Research and Treatment 98 (2006) 115-120
18. Misdorp W., Else R., Hellmen E., and Lipscomb T. Histological Classification of Mammary Tumours of the Dog and the Cat. 2nd Edit. (1999), Armed Forces Institute of Pathology, Washington DC pp. 1-59
19. Mohammed S., Khan K., Sellers R., Hayek M., DeNicola D., Wu L., Bonney P., and Knapp D. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins, Leukotrienes and Essential Fatty Acids 70 (2004) 479-483
20. Muller-Decker K., Berger I., Ackermann K., Ehemann V., Zoubova S., Aulmann S., Pyerin W., and Furstenberger G. Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2. American Journal of Pathology 166 (2005) 575-584
21. Nelson L., and Kelly W. Changes in canine mammary gland histology during the estrous cycle. Toxicology and Applied Pharmacology 27 (1974) 113-122
22. Parrett M., Harris R., Joarder F., Ross M., Clausen K., and Robertson F. Cyclooxygenase-2 gene expression in human breast cancer. International Journal of Oncology 10 (1997) 503-507
23. Perrone G., Zagami M., Altomare V., Battista C., Morini S., and Rabitti C. COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast. Virchows Archiv 451 (2007) 1039-1045
24. Queiroga F., Alves A., Pires I., and Lopes C. Expression of COX-1 and COX-2 in canine mammary tumours. Journal of Comparative Pathology 136 (2007) 177-185
25. Rhem S., Stanislaus D., and Williams A. Estrous cycle-dependent histology and review of sex steroid receptor expression in dog reproductive tissues and mammary gland and associated hormone levels. Birth Defects Research. Part B, Developmental and Reproductive Toxicology 80 (2007) 233-245
26. Ristimaki A., Sivula A., Lundin J., Lundin M., Salminen T., Haglund C., Joensuu H., and Isola J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Research 62 (2002) 632-635
27. Russo J., and Russo I. Development of the human mammary gland. In: Neville M., and Daniel C. (Eds). The Mammary Gland Development, Regulation and Function (1987), Plenum Publishing Inc., New York 67-93
28. Taketo M. Cyclooxygenase-2 inhibitors in tumorigenesis. Journal of the National Cancer Institute 90 (1998) 1529-1536
29. Thomas W., Caiazza F., and Harvey B. Estrogen, phospholipase A and breast cancer. Frontiers in Bioscience 13 (2008) 2604-2613
30. Wang M., Honn K., and Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Reviews 26 (2007) 525-534